Researchers want to analyze the hepatitis B vaccine in Guinea-Bissau.A nurse loads a syringe with a vaccine against hepatitis in Lynwood, Calif., on Aug. 27, 2013. Robyn Beck/AFP via Getty Images1/22/2026|Updated: 1/22/2026A vaccine trial partially funded by the United States is on hold pending a review, African officials announced on Jan. 22.There is no record of an ethics committee meeting to review the trial, Guinea-Bissau’s Health Minister Quinhi Nantot said during a news conference held by the Africa Centers for Disease Control and Prevention.Zachary StieberSenior ReporterZachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]Author’s Selected Articles
US-Funded Vaccine Trial in Africa on Hold: Health Minister
Date:
